These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1233201)

  • 1. Properties of acebutolol in twenty patients with cardiac arrhythmias.
    Biron P; Proulx A; Lapointe L; Nadeau R; Tremblay G
    Eur J Clin Pharmacol; 1975; 8(1):11-4. PubMed ID: 1233201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acebutolol in supraventricular arrhythmias.
    Aronow WS; Van Camp S; Turbow M; Whittaker K; Lurie M
    Clin Pharmacol Ther; 1979 Feb; 25(2):149-53. PubMed ID: 365429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective treatment of supraventricular arrhythmias with acebutolol.
    Williams DO; Tatelbaum R; Most AS
    Am J Cardiol; 1979 Sep; 44(3):521-5. PubMed ID: 382821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of ventricular ectopic beats with oral acebutolol: a double-blind, randomized crossover study.
    Lui HK; Lee G; Dhurandhar R; Hungate EJ; Laddu A; Dietrich P; Mason DT
    Am Heart J; 1983 May; 105(5):722-6. PubMed ID: 6846115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acebutolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects.
    Singh BN; Thoden WR; Wahl J
    Pharmacotherapy; 1986; 6(2):45-63. PubMed ID: 3012486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of cardioselective beta adrenergic blockade with intravenously administered tolamolol in the treatment of cardiac arrhythmias.
    Amsterdam EA; Lee G; Morrison S; Tonkin MJ; DeMaria AN; Mason DT
    Am J Cardiol; 1976 Aug; 38(2):195-9. PubMed ID: 7952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-arrhythmic properties of acebutolol (Bay c 7705), a new cardioselective beta-adrenergic blocking agent: a preliminary report.
    Burckhardt K; Raeder E; Ebner F
    Curr Med Res Opin; 1977; 4(7):496-500. PubMed ID: 844327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of premature ventricular complexes with acebutolol.
    Aronow WS; Turbow M; Lurie M; Whittaker K; Van Camp S
    Am J Cardiol; 1979 Jan; 43(1):106-8. PubMed ID: 758758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic use of acebutolol in the treatment of cardiac arrhythmias.
    O'Reilly M
    Am Heart J; 1991 Apr; 121(4 Pt 1):1185-93. PubMed ID: 2008843
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of acebutolol on cardiac arrhythmias in patients with chronic coronary artery disease.
    Burckhardt D; Raeder EA
    Am Heart J; 1980 Apr; 99(4):443-5. PubMed ID: 6102434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of early ventricular arrhythmia by acebutolol in patients with acute myocardial infarction.
    Ahumada GG; Karlsberg RP; Jaffe AS; Ambos HD; Sobel BE; Roberts R
    Br Heart J; 1979 Jun; 41(6):654-9. PubMed ID: 465240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acebutolol therapy for ventricular arrhythmia. A randomized placebo-controlled double-blind multicenter study.
    De Soyza N; Shapiro W; Chandraratna PA; Aronow WS; Laddu AR; Thompson CH
    Circulation; 1982 Jun; 65(6):1129-33. PubMed ID: 7042111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acebutolol.
    Med Lett Drugs Ther; 1985 Jul; 27(691):58-60. PubMed ID: 3892259
    [No Abstract]   [Full Text] [Related]  

  • 14. The long-term suppression of ventricular arrhythmia by oral acebutolol in patients with coronary artery disease.
    de Soyza N; Kane JJ; Murphy ML; Laddu AR; Doherty JE; Bissett JK
    Am Heart J; 1980 Nov; 100(5):631-8. PubMed ID: 6778183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acebutolol: ten years of experience.
    De Bono G; Kaye CM; Roland E; Summers AJ
    Am Heart J; 1985 May; 109(5 Pt 2):1211-3. PubMed ID: 2859785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acebutolol and propranolol on premature ventricular complexes.
    Aronow WS; Wong R; Plasencia G; Landa D; Turbow M
    Clin Pharmacol Ther; 1980 Jul; 28(1):28-31. PubMed ID: 6993085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravenous acebutolol in supraventricular arrhythmias and ventricular extrasystole. Experience in 22 cases].
    Yenes A; Chamorro H; González G
    Rev Med Chil; 1984 Jan; 112(1):32-5. PubMed ID: 6204365
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemodynamic effects of intravenous acebutolol in the acute phase of myocardial infarction].
    Metzger JP; Montgermont P; N'Koua JL; Baubion N; Adams C; Meilhac B; Le Pailleur C; Vacheron A
    Ann Cardiol Angeiol (Paris); 1985 Jun; 34(6):377-80. PubMed ID: 4026163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic significance of dosing intervals in beta receptor blocking therapy of hypertension with acebutolol.
    Frick MH; Kala R
    Am J Cardiol; 1981 Nov; 48(5):911-6. PubMed ID: 6118059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
    Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
    J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.